ANGION BIOMEDICA CORP (ANGN)
US03476J1079 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 29.22M | 50.49M | 88.76M | 34.61M | 5.57M | |||
| Receivables | 9.68M | 0.00 | 806.00K | 5.00M | 440.00K | |||
| Other Current Assets | 1.73M | 943.00K | 1.69M | 2.69M | 100.00K | |||
| Total Current Assets | 40.63M | 51.43M | 91.25M | 42.30M | 6.11M | |||
| Non-Current Assets | ||||||||
| PPE Net | 126.00K | 425.00K | 4.44M | 4.23M | 4.78M | |||
| Investments And Advances | 150.00K | 874.00K | 723.00K | 820.00K | 1.00M | |||
| Other Non-Current Assets | 864.00K | 61.00K | 106.00K | N/A | N/A | |||
| Total Non-Current Assets | 1.14M | 1.36M | 5.27M | 5.05M | 5.78M | |||
| TOTAL ASSETS | 41.77M | 52.79M | 96.51M | 47.35M | 11.89M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 51.43M | 5.85M | |||
| Current Portion Of LT Debt. | 0.00 | 67.00K | 58.00K | N/A | N/A | |||
| Accrued Expenses | 1.09M | 1.99M | 4.11M | 7.28M | 3.69M | |||
| Accounts Payable | 692.00K | 2.72M | 4.71M | 5.58M | 11.24M | |||
| Other Current Liabilities | 251.00K | 1.59M | 2.42M | 43.17M | 5.79M | |||
| Total Current Liabilities | 2.03M | 6.37M | 11.30M | 107.45M | 26.58M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 168.00K | 235.00K | 640.00K | 0.00 | |||
| Other Non-Current Liabilities | 70.00K | 2.48M | 3.48M | 29.71M | 3.90M | |||
| Total Non-Current Liabilities | 70.00K | 2.65M | 3.71M | 30.35M | 3.89M | |||
| TOTAL LIABILITIES | 2.10M | 9.02M | 15.01M | 137.80M | 30.47M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -258.48M | -253.94M | -215.13M | -160.56M | -80.46M | |||
| Additional Paid In Capital | 297.68M | 297.33M | 296.44M | 72.14M | 63.58M | |||
| Common Shares | 301.00K | 301.00K | 300.00K | 160.00K | 100.00K | |||
| Treasury Stock | N/A | N/A | 0.00 | -1.85M | -1.81M | |||
| Other Shareholders' Equity | 165.00K | 86.00K | -103.00K | -330.00K | N/A | |||
| Shares Outstanding | 30.11M | 30.11M | 29.96M | 15.32M | 9.98M | |||
| Tangible Book Value per Share | 1.32 | 1.45 | 2.72 | -5.90 | -1.86 | |||
| Total Shareholders' Equity | 39.67M | 43.77M | 81.51M | -90.45M | -18.59M | |||
| TOTAL LIABILITIES AND EQUITY | 41.77M | 52.79M | 96.51M | 47.35M | 11.89M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.00 | 0.00 | -0.58 | N/A | |||
| Current Ratio | 20.00 | 8.08 | 8.08 | 0.39 | 0.23 | |||
| Return On Assets (ROA) | -69.68% | -73.51% | -56.54% | -169.19% | -341.97% | |||
| Return On Equity (ROE) | -73.37% | -88.66% | -66.95% | N/A | N/A | |||
All data in USD